Endovascular Treatment for Lower-extremity Arterial Thrombosis in a Patient with Congenital Afibrinogenemia and a History of Bleeding Complications

Overview

Journal Intern Med

Specialty General Medicine

Date 2021 Aug 2

PMID 34334565

Authors

Daisuke Hiramatsu

Yoshito Ogihara

Takeshi Matsumoto

Kei Sato

Akihiro Takasaki

Tairo Kurita

Ryuji Okamoto

Hideo Wada

Kaoru Dohi

Affiliations

Soon will be listed here.

Abstract

Congenital afibrinogenemia is a rare autosomal recessive blood disorder that accompanies thrombotic complications and is associated with bleeding tendency. The management of these opposing complications remains a challenge. Endovascular treatment (EVT) for peripheral arterial thrombosis has not been described in previous studies. A 57-year-old man with congenital afibrinogenemia developed back pain and left lower leg pain. The cause of the pain was confirmed to be renal infarction and lower extremity arterial thrombosis by Doppler ultrasound and contrast-enhanced computed tomography. He was treated with EVT for the lower extremity arterial thrombosis, leading to an excellent short-term improvement without bleeding.

References

De Bosch N, Mosesson M, Ruiz-Saez A, Echenagucia M . Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I). Thromb Haemost. 2002; 88(2):253-8. View

Levy J, Welsby I, Goodnough L . Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion. 2013; 54(5):1389-405. DOI: 10.1111/trf.12431. View

Dupuy E, Soria C, Molho P, Zini J, Rosenstingl S, Laurian C . Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin. Thromb Res. 2001; 102(3):211-9. DOI: 10.1016/s0049-3848(01)00247-x. View

Moerloose P, Casini A, Neerman-Arbez M . Congenital fibrinogen disorders: an update. Semin Thromb Hemost. 2013; 39(6):585-95. DOI: 10.1055/s-0033-1349222. View

Margaglione M, Vecchione G, Cappucci F, Macarini L, DAndrea G, Di Matteo C . Venous thrombosis in afibrinogenemia: a successful use of rivaroxaban. Haemophilia. 2015; 21(5):e431-3. DOI: 10.1111/hae.12734. View

de Moerloose P, Schved J, Nugent D . Rare coagulation disorders: fibrinogen, factor VII and factor XIII. Haemophilia. 2016; 22 Suppl 5:61-5. DOI: 10.1111/hae.12965. View

Falsoleiman H, Daloee M, Dehghani M, Rohani A, Bayani B . Percutaneous coronary intervention in a case of afibrinogenemia. Asian Cardiovasc Thorac Ann. 2014; 21(3):358-9. DOI: 10.1177/0218492312455180. View

Sartori M, Teresa S, Milan M, Marta M, de Bon E, Emiliano D . Thrombosis of abdominal aorta in congenital afibrinogenemia: case report and review of literature. Haemophilia. 2014; 21(1):88-94. DOI: 10.1111/hae.12507. View

Mosesson M . Update on antithrombin I (fibrin). Thromb Haemost. 2007; 98(1):105-8. View

10.

Bornikova L, Peyvandi F, Allen G, Bernstein J, Manco-Johnson M . Fibrinogen replacement therapy for congenital fibrinogen deficiency. J Thromb Haemost. 2011; 9(9):1687-704. DOI: 10.1111/j.1538-7836.2011.04424.x. View

11.

Castaman G, Lunardi M, Rigo L, Mastroeni V, Bonoldi E, Rodeghiero F . Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo- and afibrinogenemia. Haemophilia. 2009; 15(2):533-7. DOI: 10.1111/j.1365-2516.2009.01939.x. View

12.

Ozdemir M, Isik B, Patiroglu T, Karakukcu M, Mutlu F, Yilmaz E . A case of congenital afibrinogenemia complicated with thromboembolic events that required repeated amputations. Blood Coagul Fibrinolysis. 2014; 26(3):354-6. DOI: 10.1097/MBC.0000000000000200. View

13.

Ozker E, Atalay F, Gulmez O, Saritas B . Treating a Patient of Dysfibrinogenemia with Acute Thromboembolism by Rivaroxaban and Cilostazol. Indian J Hematol Blood Transfus. 2017; 33(3):431-433. PMC: 5544642. DOI: 10.1007/s12288-016-0751-2. View

14.

Kumar N, Padma Kumar R, Ramesh B, Garg N . Afibrinogenaemia: a rare cause of young myocardial infarct. Singapore Med J. 2008; 49(4):e104-6. View

15.

Schror K . The pharmacology of cilostazol. Diabetes Obes Metab. 2002; 4 Suppl 2:S14-9. DOI: 10.1046/j.1463-1326.2002.0040s2s14.x. View

16.

Korte W, Poon M, Iorio A, Makris M . Thrombosis in Inherited Fibrinogen Disorders. Transfus Med Hemother. 2017; 44(2):70-76. PMC: 5425758. DOI: 10.1159/000452864. View

17.

Nagler M, Kremer Hovinga J, Alberio L, Peter-Salonen K, von Tengg-Kobligk H, Lottaz D . Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review. Thromb Haemost. 2016; 116(4):722-32. DOI: 10.1160/TH16-02-0082. View

18.

Le Quellec S, Desjonqueres A, Rugeri L, Desmurs Clavel H, Farhat F, Mechtouff L . Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency. Thromb J. 2018; 16:6. PMC: 5883424. DOI: 10.1186/s12959-018-0162-8. View